Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.

BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Z IzsvákZ Ivics

Abstract

Recent results confirm that long-term expression of therapeutic transgenes can be achieved by using a transposon-based system in primary stem cells and in vivo. Transposable elements are natural DNA transfer vehicles that are capable of efficient genomic insertion. The latest generation, Sleeping Beauty transposon-based hyperactive vector (SB100X), is able to address the basic problem of non-viral approaches - that is, low efficiency of stable gene transfer. The combination of transposon-based non-viral gene transfer with the latest improvements of non-viral delivery techniques could provide a long-term therapeutic effect without compromising biosafety. The new challenges of pre-clinical research will focus on further refinement of the technology in large animal models and improving the safety profile of SB vectors by target-selected transgene integration into genomic "safe harbors." The first clinical application of the SB system will help to validate the safety of this approach.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J A KassisN Perrimon
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Aug 31, 2000·Journal of Molecular Biology·Z IzsvákR H Plasterk
Apr 19, 2002·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Jun 27, 2002·Journal of Molecular Biology·Zongbin CuiPerry B Hackett
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Dec 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eugenio MontiniMarkus Grompe
Apr 2, 2003·Nature Medicine·C BoniniC Bordignon
May 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yunxia ZhuDaniel F Voytas
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aron M GeurtsPerry B Hackett
Aug 26, 2003·FEBS Letters·Mónika SzabóFerenc Olasz
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lalitha R BelurR Scott McIvor
Jan 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher BaumDavid A Williams
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zsuzsanna Izsvák, Zoltán Ivics
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hatem ZayedZoltán Ivics
Jul 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li LiuBradley S Fletcher
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·James E HagstromJon A Wolff
Oct 14, 2004·Journal of Virology·Anna NarezkinaRichard A Katz
Jan 25, 2005·Journal of Molecular Biology·Geyi LiuPerry B Hackett
Mar 4, 2005·Molecular and Cellular Biology·Stephen R YantMark A Kay
May 26, 2005·Investigative Ophthalmology & Visual Science·Thomas W ChalbergMichele P Calos
Sep 10, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·James BausBradley S Fletcher
Oct 26, 2005·Advances in Genetics·Ernst WagnerSabine Boeckle
Dec 22, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andrew WilberR Scott McIvor
Jan 18, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·William J BowersHoward J Federoff
Feb 9, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li LiuBradley S Fletcher

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Hematologic Malignancy Reports·Chitra HosingElizabeth Shpall
Jul 11, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katrin VoigtZoltán Ivics
Feb 28, 2013·Molecular Therapy. Nucleic Acids·Nynne SharmaJacob Giehm Mikkelsen
Aug 27, 2011·Human Gene Therapy·Zoltán Ivics, Zsuzsanna Izsvák
Apr 5, 2011·Human Molecular Genetics·Elena L AronovichPerry B Hackett
Apr 21, 2011·Human Molecular Genetics·Lisa J Scherer, John J Rossi
Dec 1, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Katharina KatterZsuzsanna Izsvák
Dec 6, 2012·Journal of Immunotherapy·Richard A Morgan
Jul 6, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sui Huang
Dec 11, 2013·Journal of Biomedical Science·Kristian Alsbjerg SkipperJacob Giehm Mikkelsen
Oct 24, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xianghong LiNancy L Craig
May 9, 2014·Molecular Biology and Evolution·Rebeca Campos-SánchezKateryna D Makova
Jun 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Xianghong LiNancy L Craig
Aug 6, 2014·Human Gene Therapy·Kelly M Podetz-PedersenR Scott McIvor
Jun 6, 2013·BMC Biotechnology·Rudolf HaaseManfred Ogris
Dec 20, 2011·Expert Opinion on Biological Therapy·Marta SwierczekZoltán Ivics
Jun 12, 2012·Expert Opinion on Biological Therapy·Mario Di MatteoThierry Vandendriessche
Jan 13, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andreas Gogol-DöringZoltán Ivics
Jul 7, 2011·Biotechnology and Bioengineering·Chiu-Ling ChenYu-Chen Hu
Mar 4, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hiu Man ViecelliBeat Thöny
Nov 19, 2013·Cytotherapy·Usanarat AnurathapanJuan F Vera
Oct 22, 2011·Mobile Genetic Elements·Rasmus O Bak, Jacob Giehm Mikkelsen
Aug 3, 2016·The Journal of Clinical Investigation·Partow KebriaeiLaurence J N Cooper
Oct 5, 2016·Critical Reviews in Biochemistry and Molecular Biology·Suneel A NarayanavariZsuzsanna Izsvák
Apr 13, 2017·Critical Reviews in Biochemistry and Molecular Biology·Michael HudecekZoltán Ivics
Dec 26, 2018·Proteins·Christopher M SingerIrina V Nesmelova
Aug 14, 2020·Genes·Carlos G Moscoso, Clifford J Steer
May 26, 2017·Biomedicines·Richard A Morgan, Benjamin Boyerinas
Jun 8, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hyun-Ji ChoiWoo-Chan Son

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.